125 related articles for article (PubMed ID: 33634859)
41. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.
Burgess JR; Dwyer T; McArdle K; Tucker P; Shugg D
J Clin Endocrinol Metab; 2000 Apr; 85(4):1513-7. PubMed ID: 10770190
[TBL] [Abstract][Full Text] [Related]
42. The effect of nutritional habits and addictions on the incidence of thyroid carcinoma in the Olsztyn province of Poland.
Bandurska-Stankiewicz E; Aksamit-Białoszewska E; Rutkowska J; Stankiewicz A; Shafie D
Endokrynol Pol; 2011; 62(2):145-50. PubMed ID: 21528477
[TBL] [Abstract][Full Text] [Related]
43. A case-control study of papillary thyroid cancer in children and adolescents.
Zivaljevic V; Tausanovic K; Sipetic S; Paunovic I; Diklic A; Kovacevic B; Stojanovic D; Zivic R; Stanojevic B; Kalezic N
Eur J Cancer Prev; 2013 Nov; 22(6):561-5. PubMed ID: 23512068
[TBL] [Abstract][Full Text] [Related]
44. Second primary breast and thyroid cancers (Israel).
Sadetzki S; Calderon-Margalit R; Peretz C; Novikov I; Barchana M; Papa MZ
Cancer Causes Control; 2003 May; 14(4):367-75. PubMed ID: 12846369
[TBL] [Abstract][Full Text] [Related]
45. Case-control study of female thyroid cancer--menstrual, reproductive and hormonal factors.
Zivaljevic V; Vlajinac H; Jankovic R; Marinkovic J; Dzodic R; Sipeti Grujii S; Paunovic I; Diklic A; Zivaljevic B
Eur J Cancer Prev; 2003 Feb; 12(1):63-6. PubMed ID: 12548112
[TBL] [Abstract][Full Text] [Related]
46. Case-control study of thyroid cancer in Northern Italy: attributable risk.
Fioretti F; Tavani A; Gallus S; Franceschi S; Negri E; La Vecchia C
Int J Epidemiol; 1999 Aug; 28(4):626-30. PubMed ID: 10480688
[TBL] [Abstract][Full Text] [Related]
47. Endocrine cancer in Iran: based on cancer registry system.
Haghpanah V; Soliemanpour B; Heshmat R; Mosavi-Jarrahi AR; Tavangar SM; Malekzadeh R; Larijani B
Indian J Cancer; 2006; 43(2):80-5. PubMed ID: 16790945
[TBL] [Abstract][Full Text] [Related]
48. Hair Coloring, Stress, and Smoking Increase the Risk of Breast Cancer: A Case-Control Study.
Dianatinasab M; Fararouei M; Mohammadianpanah M; Zare-Bandamiri M; Rezaianzadeh A
Clin Breast Cancer; 2017 Dec; 17(8):650-659. PubMed ID: 28549689
[TBL] [Abstract][Full Text] [Related]
49. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females.
Mack WJ; Preston-Martin S; Bernstein L; Qian D; Xiang M
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):991-7. PubMed ID: 10566554
[TBL] [Abstract][Full Text] [Related]
50. An epidemiologic study of thyroid cancer in Hawaii.
Kolonel LN; Hankin JH; Wilkens LR; Fukunaga FH; Hinds MW
Cancer Causes Control; 1990 Nov; 1(3):223-34. PubMed ID: 2102295
[TBL] [Abstract][Full Text] [Related]
51. Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.
Song Y; Lee HS; Park G; Kang SW; Lee JW
Front Endocrinol (Lausanne); 2022; 13():893461. PubMed ID: 35832430
[TBL] [Abstract][Full Text] [Related]
52. Prospective study of transfusion history and thyroid cancer incidence among females in Japan.
Fujino Y; Tamakoshi A; Hoshiyama Y; Mikami H; Okamoto N; Ohno Y; Yoshimura T
Int J Cancer; 2004 Nov; 112(4):722-5. PubMed ID: 15382057
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for thyroid cancer.
Sokić SI; Adanja BJ; Vlajinac HD; Janković RR; Marinković JP; Zivaljević VR
Neoplasma; 1994; 41(6):371-4. PubMed ID: 7870223
[TBL] [Abstract][Full Text] [Related]
54. The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China.
Wang M; Gong WW; Lu F; Hu RY; He QF; Yu M
BMC Endocr Disord; 2021 Jan; 21(1):21. PubMed ID: 33509182
[TBL] [Abstract][Full Text] [Related]
55. Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam.
Monachese M; Mankaney G; Lopez R; O'Malley M; Laguardia L; Kalady MF; Church J; Shin J; Burke CA
Fam Cancer; 2019 Jan; 18(1):75-82. PubMed ID: 30003385
[TBL] [Abstract][Full Text] [Related]
56. Thyroid cancer, clinical and hystopathological study on patients under 25 years in Tabriz, Iran (2000-2012).
Sokouti M; Montazeri V; Fakhrjou A; Samankan S; Goldust M
Pak J Biol Sci; 2013 Dec; 16(24):2003-8. PubMed ID: 24517019
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis.
Chenbhanich J; Atsawarungruangkit A; Korpaisarn S; Phupitakphol T; Osataphan S; Phowthongkum P
Fam Cancer; 2019 Jan; 18(1):53-62. PubMed ID: 29663106
[TBL] [Abstract][Full Text] [Related]
58. Differentiated thyroid carcinoma risk factors in French Polynesia.
Xhaard C; Ren Y; Clero E; Maillard S; Brindel P; Rachedi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Drozdovitch V; Doyon F; Rubino C; de Vathaire F
Asian Pac J Cancer Prev; 2014; 15(6):2675-80. PubMed ID: 24761883
[TBL] [Abstract][Full Text] [Related]
59. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East.
Memon A; Darif M; Al-Saleh K; Suresh A
Int J Cancer; 2002 Jan; 97(1):82-9. PubMed ID: 11774247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
